📰 Codexis Inc News
Page 9 - Codexis Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Codexis Inc. Real-time updates on events, politics, business and more.
August 24, 2023
In this article, we will take a look at the 11 best long-term penny stocks to buy now. To see more such companies, go directly to 5 Best Long-Term Penny Stocks to Buy Now. The Federal Reserve’s historic battle against inflation that started in 2022 has highlighted the importance of an already-known fact: if you […]
August 20, 2023
StockNews.com began coverage on shares of Codexis (NASDAQ:CDXS – Free Report) in a report released on Thursday morning. The brokerage issued a sell rating on the biotechnology company’s stock. A number of other brokerages also recently weighed in on CDXS. Stifel Nicolaus decreased their price objective on shares of Codexis from $9.00 to $5.00 and […]
August 18, 2023
A genetic metabolic condition called Phenylketonuria Therapeutics Market affects how the body processes protein. Phenylalanine is an amino acid that patients with PKU are unable to effectively break down, which can result in the accumulation of harmful chemicals in the body. PKU can result in severe intellectual dis...
August 17, 2023
Shares of Codexis, Inc. (NASDAQ:CDXS – Get Free Report) have been assigned a consensus rating of “Moderate Buy” from the five brokerages that are currently covering the firm, MarketBeat Ratings reports. Two equities research analysts have rated the stock with a hold recommendation and three have given a buy recommendation to the company. The average […]
August 17, 2023
Codexis, Inc. (NASDAQ:CDXS – Get Free Report) saw a significant drop in short interest in July. As of July 31st, there was short interest totalling 2,750,000 shares, a drop of 6.5% from the July 15th total of 2,940,000 shares. Based on an average daily trading volume, of 1,060,000 shares, the short-interest ratio is presently 2.6 […]
August 15, 2023
Codexis (NASDAQ:CDXS – Free Report) had its target price trimmed by Stifel Nicolaus from $9.00 to $5.00 in a report issued on Monday, MarketBeat Ratings reports. The brokerage currently has a buy rating on the biotechnology company’s stock. Several other equities research analysts have also issued reports on the stock. HC Wainwright lowered shares of […]
August 11, 2023
White Pine Capital LLC increased its position in Codexis, Inc. (NASDAQ:CDXS – Free Report) by 13.4% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 249,106 shares of the biotechnology company’s stock after purchasing an additional 29,366 shares during the quarter. White Pine Capital LLC […]
August 11, 2023
White Pine Capital LLC raised its holdings in shares of Codexis, Inc. (NASDAQ:CDXS – Free Report) by 13.4% during the first quarter, according to its most recent filing with the SEC. The firm owned 249,106 shares of the biotechnology company’s stock after purchasing an additional 29,366 shares during the period. White Pine Capital LLC’s holdings […]
August 11, 2023
/PRNewswire/ -- Technavio, a leading provider of industry news and insights, is pleased to announce its latest report on the Global Synthetic Biology Market....